Based on the observed inhibition of metastatic KRAS-mutated CRC tumor growth following LS-1-2 treatment, we investigated whether LS-1-2 could directly prevent liver metastasis in KRAS-mutated colorectal cancer. The gene discussed is KRAS; the disease is colorectal carcinoma.